Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS · Delayed Price · Currency is USD
0.1831
0.00 (0.00%)
Jul 28, 2026, 4:00 PM EST

Ampio Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-9.52-9.52-20.38-20.57-15.83-18.58
Net Income
-8.63-8.63-16.34-17.08-15.89-13.63
Earnings Per Share
-10.66-10.66-29.32-30.10-27.59-42.32
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
4.124.1212.6934.7817.617.69
Total Debt
0.450.450.81.191.211.47
Net Cash (Debt)
3.673.6711.8833.5816.46.23
Net Cash Growth
-69.10%-69.10%-64.61%104.73%163.50%-17.93%
Net Cash Per Share
4.534.5315.7749.1528.4714.24

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
-8.56-8.56-21.13-14.09-14.73-15.38
Capital Expenditures
----0.1-0.06-0.02
Free Cash Flow
-8.56-8.56-21.13-14.19-14.79-15.41
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
------